Skip to main content

Advertisement

SpringerLink
Log in

Antibody–drug conjugates

  • From the Analyst's Couch
  • Published:

From Nature Reviews Drug Discovery

View current issue Sign up to alerts

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Figure 1: Antibody–drug conjugate structure and desired characteristics.

References

  1. Hughes, B. Antibody–drug conjugates for cancer: poised to deliver? Nature Rev. Drug Discov. 9, 665–667 (2010).

    Article  CAS  Google Scholar 

  2. Lash, A. Antibody–drug conjugates: the next generation of moving parts. START-UP 27 Dec 2011 (Article #2011900259).

  3. Seattle Genetics. 2012 press releases. Seattle Genetics website [online], (2012).

Download references

Author information

Authors and Affiliations

  1. Rachel S. Zolot, Satarupa Basu and Ryan P. Million are at Trinity Partners, 675 Third Avenue, 20th Floor, New York, New York 10017, USA.,

    Rachel S. Zolot, Satarupa Basu & Ryan P. Million

Authors
  1. Rachel S. Zolot
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Satarupa Basu
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Ryan P. Million
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding authors

Correspondence to Rachel S. Zolot or Ryan P. Million.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Zolot, R., Basu, S. & Million, R. Antibody–drug conjugates. Nat Rev Drug Discov 12, 259–260 (2013). https://doi.org/10.1038/nrd3980

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/nrd3980

  • Springer Nature Limited

This article is cited by

Search

Navigation